These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7088691)
1. [Calcium blocking as a therapeutic principle]. Ekelund LG Nord Med; 1982 Apr; 97(4):110-3. PubMed ID: 7088691 [No Abstract] [Full Text] [Related]
2. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion]. Litvitskiĭ PF Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem. Schwartz DJ; Wasserstrom JA; Fozzard HA Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044 [No Abstract] [Full Text] [Related]
7. [New approach to the development of Ca antagonists]. Baba A; Arita M; Masuyama Y Nihon Rinsho; 1989 Aug; 47(8):1788-93. PubMed ID: 2585742 [No Abstract] [Full Text] [Related]
8. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil. Shulman A; Jagoda J; Laycock G; Kelly H Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731 [TBL] [Abstract][Full Text] [Related]
9. [Protective action of the calcium antagonist foridon in acute myocardial ischemia]. Vitolinia RO; Berzinia DA; Velena AKh; Vutsina IA; Kimenis AA Kardiologiia; 1987 Mar; 27(3):90-3. PubMed ID: 3586490 [No Abstract] [Full Text] [Related]
10. Calcium blockers in coronary heart disease. Part II. Pepine CJ; Conti CR Mod Concepts Cardiovasc Dis; 1981 Dec; 50(12):67-72. PubMed ID: 7339485 [No Abstract] [Full Text] [Related]
11. Calcium-channel blocking agents: current indications and potential uses. Pine RM Clin Ther; 1984; 6(3):245-51. PubMed ID: 6373005 [No Abstract] [Full Text] [Related]
12. Calcium channel blockers: an evidence-based review. Waters D Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842 [TBL] [Abstract][Full Text] [Related]
13. Cardioprotection quo vadis? The role of nifedipine. 5-6 November 1982, Amsterdam, The Netherlands. Eur Heart J; 1983 May; 4 Suppl C():1-135. PubMed ID: 6617691 [No Abstract] [Full Text] [Related]
14. [KHK and treatment with calcium antagonists]. Internist (Berl); 1996 Jan; 37(1 Suppl Khk Und D):1-8. PubMed ID: 9541669 [No Abstract] [Full Text] [Related]
15. [Hypertension, coronary disease and calcium antagonists]. Dal Palù C Cardiologia; 1984; 29(9-10):433-4. PubMed ID: 6543506 [No Abstract] [Full Text] [Related]
16. Therapeutic rounds at The Milton S. Hershey Medical Center. Schneck DW Clin Ther; 1982; 5(1):14, 93-5. PubMed ID: 7127364 [No Abstract] [Full Text] [Related]
17. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers. Akintonwa DA; Odigwe CO Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744 [TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers in chronic stable angina. A review. Bala Subramanian V Herz; 1982 Aug; 7(4):211-20. PubMed ID: 7129330 [No Abstract] [Full Text] [Related]
19. Effects of calcium channel blockers on nicotine-induced hyperglycemia in the rat. Alada AR Afr J Med Med Sci; 2001; 30(1-2):57-9. PubMed ID: 14510152 [TBL] [Abstract][Full Text] [Related]